Other Information
−Removed: 10b5-1 Trading Plans – Directors and Section 16 Officers
−Removed: the three months ended December 31, 2023, none of the Company’s directors or Section 16 officers adopted or terminated any contract,
−Removed: instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions
−Removed: of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement”.
−Removed: Medical Technologies Corporation
+Added: Rule 10b5-1 Trading Plans – Directors
+Added: and Section 16 Officers
+Added: During the three months ended March 31, 2024,
+Added: none of the Company’s directors or Section 16 officers adopted or terminated any contract, instruction or written plan for the purchase
+Added: or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or
+Added: any “non-Rule 10b5-1 trading arrangement”.
+Added: NeuroOne Medical Technologies
Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.4 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).
1 unchanged sentence
Bylaws of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.5 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).
−Removed: Employment Offer Letter, dated as of November 10, 2023, by and between Christopher Volker and the Company (incorporated by reference to Exhibit 10.1 on the Registrant’s Current Report on Form 8-K filed on November 14, 2023).
−Removed: First Amendment to 2021 Inducement Plan (incorporated by reference to Exhibit 10.2 on the Registrant’s Current Report on Form 8-K filed on November 14, 2023).
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
2 unchanged sentences
Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: XBRL Instance Document.
−Removed: XBRL Taxonomy Extension Schema Document.
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document.
−Removed: XBRL Taxonomy Extension Definition Linkbase Document.
−Removed: XBRL Taxonomy Extension Label Linkbase Document.
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document.
+Added: Inline XBRL Instance Document.
+Added: Inline XBRL Taxonomy Extension Schema Document.
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Definition Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Label Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase Document.
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
−Removed: Documents are furnished
−Removed: Medical Technologies Corporation
−Removed: to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by
−Removed: the undersigned thereunto duly authorized.
−Removed: Medical Technologies Corporation
−Removed: Chief Executive
−Removed: (Principal Executive
−Removed: Ronald McClurg
+Added: Documents are furnished not filed.
+Added: NeuroOne Medical Technologies
+Added: Pursuant to the requirements of the Securities
+Added: Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: NeuroOne Medical Technologies Corporation
+Added: /s/ David Rosa
+Added: Chief Executive Officer
+Added: (Principal Executive Officer)
+Added: /s/ Ronald McClurg
Ronald McClurg
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.